REMUS logo

Remus Pharmaceuticals L

REMUS·NSE·
867.00 -32.45 (-3.61%)
Market Cap1063.03 Cr
PE Ratio27.62
Volume3,400
Day High - Low900.00 - 867.00
52W High-Low987.50 - 580.00
DocStoX Score
6.1/10
Fair
Fair Value
Sign in to see
ROE
12.20%
Average
P/E
27.62x
Fair
Debt / Equity
0.08
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day867.00
900.00
52W580.00
987.50
DocStoX take

Supported by growth (9.5) and risk (7.6), but held back by valuation (2.6). Growth looks strong at 9.5, but that is offset by valuation at 2.6. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.1
/10
Fair
Quality
Modest
ROE 12.2%
Valuation
Expensive
P/E 27.6×
Growth
Strong
Revenue +115.4% 5Y CAGR
Risk
Low risk
D/E 0.08
Momentum
Strong
70% of 52-week range

At a glance

Market Cap
₹1,063 Cr
52W High / Low
₹988 / ₹580
Dividend Yield
0.05%
Promoter Holding
70.95%
EPS (TTM)
₹31.39
Book Value
₹298.00

Key highlights

  • Revenue compounding 115% a year
  • Profit compounding 114% a year
  • Low leverage — D/E 0.08
4 Positives0 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

REMUS PHARMACEUTICALS L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.